What Calcium Deposits in Tissues Mean
Calcium deposits in tissues represent abnormal accumulation of calcium salts outside the skeletal system, occurring through three distinct pathophysiological mechanisms: dystrophic calcification (damaged tissue with normal calcium metabolism), metastatic calcification (elevated calcium-phosphate levels depositing in normal tissue), or calcinosis (normal metabolism with subcutaneous/connective tissue deposition). 1
Understanding the Three Main Types
Dystrophic Calcification
- Occurs in damaged or devitalized tissues despite normal serum calcium and phosphate levels 1, 2
- The tissue injury itself triggers calcium deposition, not metabolic abnormalities 2
- Common examples include:
- In atherosclerosis, calcium granules begin microscopically in young people within lipid-rich lesion cores, eventually combining to form large calcified structures by the fourth decade of life 3
Metastatic Calcification
- Results from elevated calcium and/or phosphate levels in the blood, causing precipitation in otherwise normal tissues 1, 2
- Associated systemic conditions include:
- In chronic kidney disease, vascular calcification involves both intimal deposits (tied to traditional risk factors) and medial deposits (related to diabetes and hypertension) 4
Calcinosis
- Occurs in persons with normal calcium metabolism, primarily affecting subcutaneous tissues, skin, and connective tissue 1, 2
- Associated with autoimmune/connective tissue diseases:
Special Clinical Entities
Calcium Pyrophosphate Deposition (CPPD)
- Represents crystal deposition in joints and cartilage, ranging from asymptomatic chondrocalcinosis to acute inflammatory arthritis 4
- Asymptomatic CPPD requires no treatment 4
- Acute attacks warrant joint aspiration with steroid injection, cool packs, and temporary rest 4
Calciphylaxis (Calcific Uremic Arteriolopathy)
- A severe, life-threatening condition involving calcification, fibrosis, and thrombosis of small-to-medium dermal vessels, primarily in end-stage kidney disease 5
- Diagnosis requires combining vascular calcification (detected by von Kossa stain) with subcutaneous small vessel thrombosis for optimal sensitivity (85%) and specificity (88%) 6
- First-line treatment includes sodium thiosulfate (12.5-25g per dialysis session, 2-3 times weekly for 3-6 months) and immediate discontinuation of vitamin K antagonists 5
- Carries extremely high mortality, primarily from sepsis of infected ulcers 5
Band Keratopathy
- Hydroxyapatite deposition in the anterior corneal surface from inflammation, local injury, or systemic hypercalcemia 4
- Generally asymptomatic; treatment reserved for cases causing glare, visual disability, or pain 4
- Managed with mechanical removal and/or EDTA chelation 4
Clinical Significance and Implications
Cardiovascular Risk
- Coronary artery calcification indicates atherosclerotic plaque burden and correlates with cardiovascular risk, though calcification itself does not determine plaque stability 4
- An Agatston score of 0 has nearly 100% negative predictive value for ruling out significant coronary stenosis 4
- Breast arterial calcification on mammography provides additional cardiovascular risk stratification beyond traditional calculators (net reclassification improvement 0.12) 4
Chronic Kidney Disease Context
- Vascular calcification in CKD represents a complex, multisystem disease requiring modification of multiple parameters 4
- Calcium-containing phosphate binders may increase vascular calcification risk, though evidence comparing calcium-free alternatives shows inconsistent benefits 4
- Currently, no direct methods exist to assess calcium balance or internal calcium fluxes, particularly calcium deposition in tissues 4
Critical Pitfalls to Avoid
- Do not assume all vascular calcification indicates unstable atherosclerotic disease—calcification can occur in stable plaques and does not necessarily predict rupture 4
- Recognize that fine calcium deposits visible only on von Kossa stain lack specificity without accompanying vessel thrombosis—this combination is needed to diagnose calciphylaxis 6
- Understand that calcium deposits in atherosclerosis persist despite aggressive lipid lowering—in primate studies, 3.5 years of drastic cholesterol reduction eliminated foam cells and lipid but left calcium deposits unchanged 3
- Avoid vitamin K antagonists in patients with end-stage renal disease—they increase calciphylaxis risk up to 11-fold 5
- Remember that bisphosphonates like alendronate inhibit bone resorption and can cause asymptomatic reductions in serum calcium (approximately 2%) and phosphate (approximately 4-6%) 7